Management of rheumatic chorea -: An observational study

被引:18
作者
Araújo, APDC [1 ]
Pádua, PAB [1 ]
Maia, HS [1 ]
机构
[1] Univ Fed Rio de Janeiro, IPPMG, Serv Neurol, Rio De Janeiro, RJ, Brazil
关键词
chorea; rheumatic fever; therapy; prognosis;
D O I
10.1590/S0004-282X2002000200008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Rheumatic chorea (RC) has recently been linked to an antibody-mediated immune mechanism. Objective/Method: To verify if this knowledge reflected in management changes we conceived a descriptive study. Results: The medical charts of 20 children (13 females) aged 6 to 12 years (mean 8 years), diagnosed as RC from June 1996 to June 1999, were reviewed. All patients received some medical treatment. Haloperidol was the most prescribed medication (15 patients - 75%). Sulpiride, diazepam and valproate were also used as symptomatic treatment. Imune-modulating therapy with prednisone was prescribed for seven children. The shortest course of chorea (16 days) occurred in a patient treated with prednisone, Conclusion: Prednisone has been prescribed for rheumatic chorea besides the traditional symptomatic approach. A great variety of antichoreic drugs are being employed.
引用
收藏
页码:231 / 233
页数:3
相关论文
共 22 条